Investigational Drug Information for Linifanib
✉ Email this page to a colleague
What is the development status for investigational drug Linifanib?
Linifanib is an investigational drug.
There have been 12 clinical trials for Linifanib.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2010.
The most common disease conditions in clinical trials are Neoplasms, Carcinoma, Hepatocellular, and Carcinoma. The leading clinical trial sponsors are Abbott, AbbVie, and Vanderbilt-Ingram Cancer Center.
Summary for Linifanib
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,131 |
| WIPO Patent Applications | 795 |
| Japanese Patent Applications | 342 |
| Clinical Trial Progress | Phase 1 (2010-01-01) |
| Vendors | 62 |
Recent Clinical Trials for Linifanib
| Title | Sponsor | Phase |
|---|---|---|
| Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma | Sir Salimullah Medical College Mitford Hospital | N/A |
| Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis | BioGene Pharmaceutical Ltd. | Phase 1/Phase 2 |
| A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors | Abbott | Phase 1 |
Clinical Trial Summary for Linifanib
Top disease conditions for Linifanib
Top clinical trial sponsors for Linifanib
US Patents for Linifanib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
